Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

In recent times, there has been a considerable increase in the use of aortic bioprostheses
(vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to …

Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Aims There are limited data on coronary obstruction following transcatheter valve-in-valve
(ViV) implantation inside failed aortic bioprostheses. The objectives of this study were to …

Background: Prosthesis–patient mismatch (PPM) after surgical aortic valve replacement
(AVR) for aortic stenosis is generally associated with worse outcomes. Transcatheter AVR …

Background: Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical
reoperation in patients with recurrent mitral valve failure after previous surgical valve repair …

Background Transcatheter aortic valve replacement (TAVR) use is increasing in patients
with longer life expectancy, yet robust data on the durability of transcatheter heart valves …

Importance More than 40 million people are living with either mitral or aortic valve disease
worldwide, and more than 180 000 heart valve replacement surgeries are performed each …

Background: Delayed coronary obstruction (DCO) is an uncommon and barely reported
complication following transcatheter aortic valve replacement (TAVR). Objectives: The aim of …